Skip to main content

Web Exclusives

FDA Alert: Pepaxto (Melphalan Flufenamide) Associated with Increased Risk of Death in Postmarketing Clinical Trial

Practice Management

Global Issues Driving US Healthcare Trends in 2021 and 2022

F. Randy Vogenberg, PhD; John Santilli, MBA

Concerns Related to Benefits and Harms of Real-World Shared Decision-Making for Lung Cancer Screening

James L. Mulshine, MD; David F. Yankelevitz, MD; Bruce Pyenson, FSA, MAAA

Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker

Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations

Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation

Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma

Zanidatamab Shows Promising Activity in Patients with HER2-Overexpressing Gastric Cancers

Wayne Kuznar

Prostate Cancer

¹⁷⁷Lu-PSMA-617 Superior to Cabazitaxel in Metastatic Prostate Cancer

Phoebe Starr

Lung Cancer, Infectious Diseases, Oncology

Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care

Walter Alexander

Page 13 of 37
Results 121 - 130 of 368